2225 — Jinhai Medical Technology Balance Sheet
0.000.00%
- HK$7.08bn
- HK$7.09bn
- SG$50.24m
Annual balance sheet for Jinhai Medical Technology, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 25.7 | 25 | 23.9 | 26.8 | 14.9 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 6.31 | 2.67 | 4.03 | 8.42 | 12.5 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 32.4 | 30.7 | 33.3 | 42.7 | 30.2 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4.29 | 1.83 | 5.73 | 6.43 | 6.3 |
Net Goodwill | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 39.4 | 33.8 | 40.3 | 62.2 | 58.9 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 13.2 | 9.47 | 14 | 21.3 | 23.4 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Liabilities | 13.9 | 9.49 | 15.9 | 24.7 | 27.1 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 25.5 | 24.3 | 24.4 | 37.5 | 31.8 |
Total Liabilities & Shareholders' Equity | 39.4 | 33.8 | 40.3 | 62.2 | 58.9 |
Total Common Shares Outstanding |